0000899243-22-001631.txt : 20220111
0000899243-22-001631.hdr.sgml : 20220111
20220111201829
ACCESSION NUMBER: 0000899243-22-001631
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220111
FILED AS OF DATE: 20220111
DATE AS OF CHANGE: 20220111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Northpond Ventures, LP
CENTRAL INDEX KEY: 0001867472
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41200
FILM NUMBER: 22525237
BUSINESS ADDRESS:
STREET 1: 7500 OLD GEORGETOWN ROAD
STREET 2: SUITE 850
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: 240-800-1200
MAIL ADDRESS:
STREET 1: 7500 OLD GEORGETOWN ROAD
STREET 2: SUITE 850
CITY: BETHESDA
STATE: MD
ZIP: 20814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Northpond Ventures GP, LLC
CENTRAL INDEX KEY: 0001867470
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41200
FILM NUMBER: 22525238
BUSINESS ADDRESS:
STREET 1: 7500 OLD GEORGETOWN ROAD
STREET 2: SUITE 850
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: 240-800-1200
MAIL ADDRESS:
STREET 1: 7500 OLD GEORGETOWN ROAD
STREET 2: SUITE 850
CITY: BETHESDA
STATE: MD
ZIP: 20814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Northpond Ventures II, LP
CENTRAL INDEX KEY: 0001869128
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41200
FILM NUMBER: 22525235
BUSINESS ADDRESS:
STREET 1: 7500 OLD GEORGETOWN ROAD
STREET 2: SUITE 850
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: 240-800-1200
MAIL ADDRESS:
STREET 1: 7500 OLD GEORGETOWN ROAD
STREET 2: SUITE 850
CITY: BETHESDA
STATE: MD
ZIP: 20814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rubin Michael P.
CENTRAL INDEX KEY: 0001867627
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41200
FILM NUMBER: 22525234
MAIL ADDRESS:
STREET 1: 7500 OLD GEORGETOWN ROAD
STREET 2: SUITE 850
CITY: BETHESDA
STATE: MD
ZIP: 20814
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Northpond Ventures GP II, LLC
CENTRAL INDEX KEY: 0001869114
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41200
FILM NUMBER: 22525236
BUSINESS ADDRESS:
STREET 1: 7500 OLD GEORGETOWN ROAD
STREET 2: SUITE 850
CITY: BESTHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: 240-800-1200
MAIL ADDRESS:
STREET 1: 7500 OLD GEORGETOWN ROAD
STREET 2: SUITE 850
CITY: BESTHESDA
STATE: MD
ZIP: 20814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vigil Neuroscience, Inc.
CENTRAL INDEX KEY: 0001827087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 10TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-254-4445
MAIL ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 10TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-11
0
0001827087
Vigil Neuroscience, Inc.
VIGL
0001867470
Northpond Ventures GP, LLC
7500 OLD GEORGETOWN ROAD, SUITE 850
BETHESDA
MD
20814
0
0
1
0
0001867472
Northpond Ventures, LP
7500 OLD GEORGETOWN ROAD, SUITE 850
BETHESDA
MD
20814
0
0
1
0
0001869114
Northpond Ventures GP II, LLC
7500 OLD GEORGETOWN ROAD, SUITE 850
BETHESDA
MD
20814
0
0
1
0
0001869128
Northpond Ventures II, LP
7500 OLD GEORGETOWN ROAD, SUITE 850
BETHESDA
MD
20814
0
0
1
0
0001867627
Rubin Michael P.
7500 OLD GEORGETOWN ROAD, SUITE 850
BETHESDA
MD
20814
0
0
1
0
Common Stock
2022-01-11
4
C
0
2831520
A
2831520
I
By: Northpond Ventures, LP
Common Stock
2022-01-11
4
C
0
1027978
A
1027978
I
By: Northpond Ventures II, LP
Common Stock
2022-01-11
4
P
0
355000
14.00
A
1382978
I
By: Northpond Ventures II, LP
Series A Preferred Stock
2022-01-11
4
C
0
2831520
D
Common Stock
2831520
0
I
By: Northpond Ventures, LP
Series B Preferred Stock
2022-01-11
4
C
0
1027978
D
Common Stock
1027978
0
I
By: Northpond Ventures II, LP
Immediately prior to the closing of the initial public offering of Vigil Neuroscience, Inc. (the "Issuer"), each share of Series A Preferred Stock, par value $0.0001 per share (the "Series A Preferred Stock"), of the Issuer and each share of Series B Preferred stock, par value $0.0001 per share of the Issuer (the "Series B Preferred Stock") automatically converted on a one-for-one basis into shares of the Issuer's common stock, par value $0.0001 per share (the "Common Stock"). The right to convert the Series A Preferred Stock and Series B Preferred Stock into Common Stock had no expiration date.
Northpond Ventures GP, LLC ("Northpond GP LLC") is the general partner of Northpond Ventures, LP ("Northpond Fund"), and Michael P. Rubin is the managing member of Northpond GP LLC. As a result, each of Northpond GP LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund. Each of Northpond GP LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
Northpond Ventures GP II, LLC ("Northpond GP II LLC") is the general partner of Northpond Ventures II, LP ("Northpond Fund II"), and Michael P. Rubin is the managing member of Northpond GP II LLC. As a result, each of Northpond GP II LLC and Mr. Rubin may be deemed to share beneficial ownership with respect to the shares held of record by Northpond Fund II. Each of Northpond GP II LLC and Mr. Rubin disclaim beneficial ownership of the securities reported herein, except to the extent of such Reporting Person's pecuniary interest therein, if any.
Northpond Ventures GP, LLC, By: /s/ Patrick Smerkers, Chief Financial Officer
2022-01-11
Northpond Ventures, LP, By: Northpond Ventures GP, LLC, its general partner, By: /s/ Patrick Smerkers, Chief Financial Officer
2022-01-11
Northpond Ventures GP II, LLC, By: /s/ Patrick Smerkers, Chief Financial Officer
2022-01-11
Northpond Ventures II, LP, By: Northpond Ventures GP II, LLC, its general partner, By: /s/ Patrick Smerkers, Chief Financial Officer
2022-01-11
/s/ Michael P. Rubin
2022-01-11